This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Oxford University Innovation Ltd, The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2023-2024.
Company Filing History:
1 out of 483 
1 out of 54 
Years Active: 2023-2024
Title: Abimael Cruz: Innovator in Pharmaceutical Compounds
Introduction
Abimael Cruz is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating proliferative disorders such as cancer. With a total of 2 patents to his name, Cruz's work is paving the way for innovative treatments.
Latest Patents
Cruz's latest patents focus on compounds of Formula I, which are designed to inhibit RAS-effector protein-protein interactions. These compounds are not only relevant for pharmaceutical compositions but also hold promise for treating various diseases where such interactions are implicated. His inventions aim to provide new avenues for addressing complex health challenges, particularly in oncology.
Career Highlights
Throughout his career, Abimael Cruz has worked with esteemed institutions such as the Institute of Cancer Research and Oxford University Innovation Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field, enhancing his research and development efforts.
Collaborations
Cruz has collaborated with notable professionals, including Terrence Rabbitts and Camilo Quevedo. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Abimael Cruz stands out as an innovative inventor in the pharmaceutical industry, with a focus on developing compounds that could significantly impact the treatment of cancer and other proliferative disorders. His contributions are vital to the ongoing quest for effective medical solutions.